FDA Archives | Novarad

Novarad’s OpenSight Augmented Reality System is the First Solution for Microsoft HoloLens 510(k) Cleared by the FDA for Medical Use

Novarad’s OpenSight Augmented Reality System is the First Solution for Microsoft HoloLens 510(k) Cleared by the FDA for Medical Use

SALT LAKE CITY—October 24, 2018— The OpenSight® Augmented Reality System is the first AR medical solution for Microsoft HoloLens cleared by the FDA receiving 510(k) clearance for use in pre-operative surgical planning. Building upon decades of Novarad’s experience in image processing, OpenSight renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them […]

Read More…


Nova3D+ advanced visualization receives FDA clearance

Good news, everyone! Our latest advancement in image processing, Nova3D+, was just cleared by the FDA for diagnostic purposes. Nova3D+ is our advanced visualization software. It provides users with high-resolution, 3D images of the body. It also enables a completely virtual, non-invasive colonoscopy—which is fascinating (more on that later). It doesn’t force you to switch […]

Read More…